Picture of Bioservo Technologies AB logo

BIOS — Bioservo Technologies AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bioservo Posts Q1 EBIT Loss of SEK 9.4 Million

Apr 25 (Reuters) - Bioservo Q1 adjusted free cash flow SEK -12.8 million.
* Q1 EBIT SEK -9.4 million
* Q1 sales SEK 4.6 million
* Q1 EBITDA SEK -8.9 million
* Q1 adjusted EPS SEK -0.49

Recent news on Bioservo Technologies AB

See all news